Is National Health Stock a Good Investment?
National Health Investment Advice | NHI |
- Examine National Health's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research National Health's leadership team and their track record. Good management can help National Health navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Diversified REITs space and any emerging trends that could impact National Health's business and its evolving consumer preferences.
- Compare National Health's performance and market position to its competitors. Analyze how National Health is positioned in terms of product offerings, innovation, and market share.
- Check if National Health pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about National Health's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in National Health Investors stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if National Health Investors is a good investment.
Sell | Buy |
Buy
Market Performance | OK | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
Examine National Health Stock
Researching National Health's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 70.0% of the company shares are owned by institutional investors. The book value of National Health was now reported as 33.73. The company has Price/Earnings To Growth (PEG) ratio of 1.99. National Health Investors last dividend was issued on the 31st of March 2025.
To determine if National Health is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding National Health's research are outlined below:
| About 70.0% of the company shares are owned by institutional investors | |
| On 29th of January 2025 National Health paid $ 0.9 per share dividend to its current shareholders | |
| Latest headline from news.google.com: 3,916 Shares in National Health Investors, Inc. Bought by Cibc World Markets Corp - MarketBeat |
National Health uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in National Health Investors. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to National Health's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 20th of February 2024 Upcoming Quarterly Report | View | |
| 14th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 20th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact National Health's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises National Health's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2009-10-30 | 2009-09-30 | 0.57 | 0.63 | 0.06 | 10 | ||
2003-07-22 | 2003-06-30 | 0.32 | 0.39 | 0.07 | 21 | ||
2024-11-05 | 2024-09-30 | 0.73 | 0.65 | -0.08 | 10 | ||
2014-05-05 | 2014-03-31 | 0.79 | 0.71 | -0.08 | 10 | ||
2011-05-05 | 2011-03-31 | 0.61 | 0.69 | 0.08 | 13 | ||
2003-10-21 | 2003-09-30 | 0.35 | 0.43 | 0.08 | 22 | ||
2013-11-04 | 2013-09-30 | 0.74 | 0.84 | 0.1 | 13 | ||
2010-08-03 | 2010-06-30 | 0.57 | 0.67 | 0.1 | 17 |
National Health Target Price Consensus
National target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. National Health's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 8 | Buy |
Most National analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand National stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of National Health Investors, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationNational Health Target Price Projection
National Health's current and average target prices are 74.12 and 79.57, respectively. The current price of National Health is the price at which National Health Investors is currently trading. On the other hand, National Health's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
National Health Market Quote on 27th of March 2025
Target Price
Analyst Consensus On National Health Target Price
National Health Analyst Ratings
National Health's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about National Health stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of National Health's financials, market performance, and future outlook by experienced professionals. National Health's historical ratings below, therefore, can serve as a valuable tool for investors.Know National Health's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as National Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading National Health Investors backward and forwards among themselves. National Health's institutional investor refers to the entity that pools money to purchase National Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Norges Bank | 2024-12-31 | 610.7 K | Bank Of New York Mellon Corp | 2024-12-31 | 557.4 K | Marshall Wace Asset Management Ltd | 2024-12-31 | 551.6 K | Millennium Management Llc | 2024-12-31 | 488.4 K | Prudential Financial Inc | 2024-12-31 | 476.4 K | Land & Buildings Investment Mgmt, Llc | 2024-12-31 | 467.1 K | Sumitomo Mitsui Trust Group Inc | 2024-12-31 | 463.4 K | Centersquare Investment Management Llc | 2024-12-31 | 394.4 K | Mirae Asset Global Etfs Holdings Ltd. | 2024-12-31 | 390.1 K | Vanguard Group Inc | 2024-12-31 | 6.4 M | Blackrock Inc | 2024-12-31 | 4.6 M |
National Health's market capitalization trends
The company currently falls under 'Mid-Cap' category with a total capitalization of 3.39 B.Market Cap |
|
National Health's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.05 | 0.08 | |
| Return On Capital Employed | 0.10 | 0.09 | |
| Return On Assets | 0.05 | 0.08 | |
| Return On Equity | 0.10 | 0.10 |
Determining National Health's profitability involves analyzing its financial statements and using various financial metrics to determine if National Health is a good buy. For example, gross profit margin measures National Health's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of National Health's profitability and make more informed investment decisions.
Evaluate National Health's management efficiency
National Health Investors has Return on Asset of 0.0463 % which means that on every $100 spent on assets, it made $0.0463 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1028 %, implying that it generated $0.1028 on every 100 dollars invested. National Health's management efficiency ratios could be used to measure how well National Health manages its routine affairs as well as how well it operates its assets and liabilities. As of now, National Health's Return On Tangible Assets are decreasing as compared to previous years. The National Health's current Return On Assets is estimated to increase to 0.08, while Return On Capital Employed is projected to decrease to 0.09. As of now, National Health's Return On Tangible Assets are decreasing as compared to previous years. The National Health's current Debt To Assets is estimated to increase to 0.44, while Total Assets are projected to decrease to under 1.4 B.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 31.59 | 16.75 | |
| Tangible Book Value Per Share | 31.59 | 25.58 | |
| Enterprise Value Over EBITDA | 15.75 | 11.82 | |
| Price Book Value Ratio | 2.22 | 2.11 | |
| Enterprise Value Multiple | 15.75 | 11.82 | |
| Price Fair Value | 2.22 | 2.11 | |
| Enterprise Value | 4.2 B | 4.4 B |
Examining the leadership quality of National Health Investors offers valuable insights into its operational efficiency and financial health. This analysis assists investors in making informed decisions regarding the stock.
Basic technical analysis of National Stock
As of the 27th of March, National Health secures the Downside Deviation of 1.52, mean deviation of 1.11, and Risk Adjusted Performance of 0.0892. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of National Health Investors, as well as the relationship between them.National Health's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific National Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on National Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases National Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
National Health's Outstanding Corporate Bonds
National Health issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. National Health Investors uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most National bonds can be classified according to their maturity, which is the date when National Health Investors has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| NHI 3 01 FEB 31 Corp BondUS63633DAF15 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Understand National Health's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing National Health's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0892 | |||
| Market Risk Adjusted Performance | 0.2804 | |||
| Mean Deviation | 1.11 | |||
| Semi Deviation | 1.34 | |||
| Downside Deviation | 1.52 | |||
| Coefficient Of Variation | 991.25 | |||
| Standard Deviation | 1.39 | |||
| Variance | 1.93 | |||
| Information Ratio | 0.0955 | |||
| Jensen Alpha | 0.1314 | |||
| Total Risk Alpha | 0.1342 | |||
| Sortino Ratio | 0.0874 | |||
| Treynor Ratio | 0.2704 | |||
| Maximum Drawdown | 5.14 | |||
| Value At Risk | (2.20) | |||
| Potential Upside | 2.33 | |||
| Downside Variance | 2.3 | |||
| Semi Variance | 1.79 | |||
| Expected Short fall | (1.10) | |||
| Skewness | (0.36) | |||
| Kurtosis | (0.18) |
| Risk Adjusted Performance | 0.0892 | |||
| Market Risk Adjusted Performance | 0.2804 | |||
| Mean Deviation | 1.11 | |||
| Semi Deviation | 1.34 | |||
| Downside Deviation | 1.52 | |||
| Coefficient Of Variation | 991.25 | |||
| Standard Deviation | 1.39 | |||
| Variance | 1.93 | |||
| Information Ratio | 0.0955 | |||
| Jensen Alpha | 0.1314 | |||
| Total Risk Alpha | 0.1342 | |||
| Sortino Ratio | 0.0874 | |||
| Treynor Ratio | 0.2704 | |||
| Maximum Drawdown | 5.14 | |||
| Value At Risk | (2.20) | |||
| Potential Upside | 2.33 | |||
| Downside Variance | 2.3 | |||
| Semi Variance | 1.79 | |||
| Expected Short fall | (1.10) | |||
| Skewness | (0.36) | |||
| Kurtosis | (0.18) |
Consider National Health's intraday indicators
National Health intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of National Health stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
National Health Corporate Filings
| 24th of March 2025 Other Reports | ViewVerify | |
F4 | 5th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10K | 25th of February 2025 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
| 19th of February 2025 Other Reports | ViewVerify |
National Stock media impact
Far too much social signal, news, headlines, and media speculation about National Health that are available to investors today. That information is available publicly through National media outlets and privately through word of mouth or via National internal channels. However, regardless of the origin, that massive amount of National data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of National Health news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of National Health relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to National Health's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive National Health alpha.
National Health Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards National Health can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
National Health Investors Historical Investor Sentiment
Investor biases related to National Health's public news can be used to forecast risks associated with an investment in National. The trend in average sentiment can be used to explain how an investor holding National can time the market purely based on public headlines and social activities around National Health Investors. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
National Health's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for National Health and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average National Health news discussions. The higher the estimate score, the more favorable the investor's outlook on National Health.
National Health Corporate Directors
| Robert Adams | Independent Director | Profile | |
| James Jobe | Independent Director | Profile | |
| Robert Webb | Independent Director | Profile | |
| Dana Hambly | Director of Investor Relations | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National Health Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National Health. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.14) | Dividend Share 3.6 | Earnings Share 3.13 | Revenue Per Share | Quarterly Revenue Growth (0.12) |
The market value of National Health Investors is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National Health's value that differs from its market value or its book value, called intrinsic value, which is National Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National Health's market value can be influenced by many factors that don't directly affect National Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between National Health's value and its price, as these two are different measures arrived at by various means. Investors typically determine if National Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.